Possible New Treatment for Multiple Sclerosis
March 31, 2017
Faster access to treatment for people with multiple sclerosis 
April 3, 2017
Show all

Hepatitis C Cures Lag While New Drugs Wait in the Wings

A how-to for navigating the hepatitis C treatment landscape.

Four years ago, the first curative pills for hepatitis C virus (HCV) were handed to patients. These drugs were a breakthrough for people infected with this pathogen. Lacking in serious side effects and eradicating the virus from the body in just 12 weeks, these so-called direct-acting antivirals (DAAs) offered a clean escape from this potentially fatal liver illness.

But with numerous DAAs now available—along with their long trail of clinical trial data—primary care physicians are left to navigate a crowded and confusing landscape for treating HCV. Controversy surrounding the cost of these drugs has also become a concern.

Read full article: Hepatitis C Cures Lag While New Drugs Wait in the Wings

Read Full Article: Hepatitis C Cures Lag While New Drugs Wait in the Wings 

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.